Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndromeYunxiong Wei, Mingfeng Zhao, Rui Sun et al.|Cancer Science|2021Cited by 71
Clinical application of targeted next-generation sequencing in pneumonia diagnosis among cancer patientsYang Ke, Bing Wei, Jiuzhou Zhao et al.|Frontiers in Cellular and Infection Microbiology|2025Cited by 7
The efficacy and safety of CD7 chimeric antigen receptor T-cell therapy for hematologic malignancies: a systematic review and meta-analysisJile Liu, Mingfeng Zhao, Xuejin Gao et al.|Frontiers in Oncology|2025Cited by 2